PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q4 EPS of ($0.35), $0.01 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $68.24 million versus the consensus estimate of $66.83 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.